Mesenchymal stem cell therapy in type 2 diabetes mellitus

By | 2018-07-16T13:20:51+00:00 July 16th, 2018|Diabetes, Mesenchymal Stem Cells|Comments Off on Mesenchymal stem cell therapy in type 2 diabetes mellitus

Over recent decades, diabetes mellitus (DM) has become one of the major public healthcare problems worldwide. It is estimated that 415 million adults have diabetes worldwide, and a further 318 million adults are estimated to have impaired glucose tolerance, and thus, be at high risk of developing diabetes in the future.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Type-II-Diabetes-May-2017.pdf” title=”MSC’s in Type II Diabetes May 2017″]

About the Author: